Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues

Flavonoids 0301 basic medicine Propiophenones Dose-Response Relationship, Drug Molecular Structure Xanthohumol analogues, Prenylated chalcones, Antiangiogenic activity, Chemopreventive agents Neovascularization, Physiologic Angiogenesis Inhibitors Apoptosis Antiangiogenic activity; Chemopreventive agents; Prenylated chalcones; Xanthohumol analogues; Pharmacology; Drug Discovery3003 Pharmaceutical Science; Organic Chemistry 3. Good health Structure-Activity Relationship 03 medical and health sciences Chalcone Cell Movement Cell Adhesion Human Umbilical Vein Endothelial Cells Humans Cells, Cultured Cell Proliferation
DOI: 10.1016/j.ejmech.2017.07.024 Publication Date: 2017-07-17T02:16:53Z
ABSTRACT
Angiogenesis induction is a hallmark of cancer. Antiangiogenic properties of Xanthohumol (XN), a naturally occurring prenylated chalcone from hops, have been widely reported. Here we describe the synthesis and study the antiangiogenic activity in vitro of a series of XN derivatives, where different substituents on the B-ring of the chalcone scaffold were inserted. The new XN derivatives inhibited human umbilical-vein endothelial cell (HUVEC) proliferation, adhesion, migration, invasion and their ability to form capillary-like structures in vitro at 10 μM concentration. The preliminary results indicate that the phenolic OH group in R, present in natural XN, is not necessary for having antiangiogenic activity. In fact, the most effective compound from this series, 13, was characterized by a para-methoxy group in R and a fluorine atom in R2 on B-ring. This study paves the way for future development of synthetic analogues of XN to be used as cancer angiopreventive and chemopreventive agents.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (27)
CITATIONS (24)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....